These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3328246)

  • 1. IgA-associated renal diseases: immunochemical studies of IgA1 proteins, circulating immune complexes, and cellular interactions.
    Mestecky J; Tomana M; Czerkinsky C; Tarkowski A; Matsuda S; Waldo FB; Moldoveanu Z; Julian BA; Galla JH; Russell MW
    Semin Nephrol; 1987 Dec; 7(4):332-5. PubMed ID: 3328246
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunopathology of glomerulonephritis with mesangial IgA deposits].
    Berthoux FC
    Nephrologie; 1989; 10(4):169-74. PubMed ID: 2699007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [IgA nephropathy (Berger's disease)].
    Romoşan I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1985; 37(1):19-29. PubMed ID: 2861634
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies.
    Czerkinsky C; Koopman WJ; Jackson S; Collins JE; Crago SS; Schrohenloher RE; Julian BA; Galla JH; Mestecky J
    J Clin Invest; 1986 Jun; 77(6):1931-8. PubMed ID: 3711340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies.
    Tomana M; Novak J; Julian BA; Matousovic K; Konecny K; Mestecky J
    J Clin Invest; 1999 Jul; 104(1):73-81. PubMed ID: 10393701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uteroglobin is essential in preventing immunoglobulin A nephropathy in mice.
    Zheng F; Kundu GC; Zhang Z; Ward J; DeMayo F; Mukherjee AB
    Nat Med; 1999 Sep; 5(9):1018-25. PubMed ID: 10470078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro solubilization of glomerular immune deposits after incubation with human IgG and IgA in membranous and IgA nephropathy.
    Cirami C; Finato V; Andreini B; Bianchi AM; Panichi V; Montagnani E; Parrini M; Gattai V; Casarosa L; Palla R
    Clin Nephrol; 1993 Sep; 40(3):185. PubMed ID: 8403576
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of immunofluorescence in the diagnosis of glomerulonephritis not related to systemic diseases.
    Morel-Maroger L; Adam C; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():81-110. PubMed ID: 4143636
    [No Abstract]   [Full Text] [Related]  

  • 9. Double immunofluorescence studies on IgA-associated immune-complexes in glomerular deposits in patients with IgA nephropathy.
    Tomino Y; Nomoto Y; Endoh M; Sakai H; Arimori S
    Tokai J Exp Clin Med; 1980 Apr; 5(2):147-9. PubMed ID: 6998050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerulonephritis and IgA deficiency.
    French MA; Shortland JR; Coward RA; Brown CB
    Clin Nephrol; 1987 Apr; 27(4):199-205. PubMed ID: 3581527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent immunologic data on human glomerulonephritis.
    Lesavre P; Monteiro RC; Chevailler A; Berger J; Halbwachs-Mecarelli L; Noël LH
    Adv Nephrol Necker Hosp; 1988; 17():57-75. PubMed ID: 3124552
    [No Abstract]   [Full Text] [Related]  

  • 12. Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy.
    McEnery PT; McAdams AJ; West CD
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():305-20. PubMed ID: 4620921
    [No Abstract]   [Full Text] [Related]  

  • 13. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC
    Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathogenetic aspects of IgA nephropathy.
    van den Wall Bake AW; Daha MR; van Es LA
    Nephrologie; 1989; 10(3):141-5. PubMed ID: 2691911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation of IgA1 and pathogenesis of IgA nephropathy.
    Novak J; Julian BA; Mestecky J; Renfrow MB
    Semin Immunopathol; 2012 May; 34(3):365-82. PubMed ID: 22434325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesangial IgA deposits.
    Morel-Maroger L; Mery JP; Robert CL; Richet G
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():301-4. PubMed ID: 4620920
    [No Abstract]   [Full Text] [Related]  

  • 17. IgA1 and IgA2 in circulating immune complexes and in renal deposits of Berger's and Schönlein-Henoch glomerulonephritis.
    Coppo R; Basolo B; Mazzucco G; Bulzomì MR; Roccatello D; Messina M; Barbiano G; Martina G; Rollino C; Piccoli G
    Proc Eur Dial Transplant Assoc; 1983; 19():648-54. PubMed ID: 6348756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of IgA dominant immune complexes on peripheral blood lymphocytes in patients with IgA nephropathy.
    Nomoto H; Tomino Y; Nomoto Y; Sakai H
    Tokai J Exp Clin Med; 1986 Mar; 11(1):13-7. PubMed ID: 3544343
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on human IgD myeloma proteins. Carbohydrate composition of intact proteins and some proteolytic fragments.
    Jefferis R; Butwell AJ; Clamp JR
    Clin Exp Immunol; 1975 Nov; 22(2):311-5. PubMed ID: 1212820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant polymeric IgA1 deposition in glomeruli in patients with IgA nephropathy.
    Suzuki S; Kobayashi H; Suzuki Y; Arakawa M
    Nihon Jinzo Gakkai Shi; 1987 Mar; 29(3):271-5. PubMed ID: 3302427
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.